Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
EXEL

Exelixis Inc. (EXEL)

NASDAQ
$68.27
-$0.23
(-0.34%)
Previous Close: ⁦$68.50⁩
Market Closed

Last updated: ⁦2026-11-19 02:28:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Exelixis Inc. (EXEL) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $68.27, with a market capitalization of $16.37B and a P/E ratio of 18.88. Over the past 52 weeks, its price has ranged from $39.71 to $73.69. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$16.37B

$68.12

$69.44

$68.09

$68.50

1.47M

2.44M

18.88

$73.69

$39.71

--

2026-09-30

Exelixis Inc. (EXEL) Latest Closing Stock Price

Exelixis Inc. (EXEL) last closed at $68.27 as of 2026-11-19 00:47:00, down 0.34% ($0.23) from the previous close of $68.50.

During the latest regular trading session, EXEL traded between $68.09 and $69.44, with a volume of 1.47M shares. The closing price was near the lower end and near the upper end of its 52-week range.

Exelixis Inc. (EXEL) 7-Day Stock Price Change

Over the past seven days, Exelixis Inc. (EXEL) moved from $71.74 to $68.27, representing a decline of 4.84% ($3.47).

The stock traded between $66.26 and $72.15 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 3.04 million shares, down versus the previous seven-day period, indicating lower trading activity.

EXEL 52-Week Price Position

Position in Range: 84.0%

52W Low$39.71
52W High$73.69

EXEL is currently trading at $68.27, placing it 84.0% of the way from its 52-week low of $39.71 to its 52-week high of $73.69. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Exelixis Inc. (EXEL)?

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Exelixis Inc. Information

Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
1,077
Exchange
NASDAQ
Company Website

EXEL News

Latest news related to Exelixis Inc. and EXEL stock.

  • Massive

    Where Will Exelixis Be in 5 Years? 1 Experimental Drug Could Change Everything

    Exelixis faces a patent cliff for its blockbuster drug Cabometyx by 2030, but the company's future hinges on zanzalintinib, an experimental cancer drug expected to receive FDA approval by March 2027. The drug showed modest survival benefits in metastatic colorectal cancer trials and could generate $5 billion in sales by 2033 if approved across multiple indications. Despite regulatory delays and competitive pressures, Exelixis' shares appear reasonably valued at 16.3x forward earnings.

    Read Full Article
  • Benzinga

    Morgan Stanley Maintains Equal-Weight on Exelixis, Lowers Price Target to $57

    Morgan Stanley analyst Sean Laaman maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and lowers the price target from $60 to $57.

    Read Full Article

Ways to Trade EXEL at MEXC

EXEL MEXC RealStocks

Own real EXEL shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

How to Buy Exelixis Inc. (EXEL) Stock on MEXC

Eligible investors can buy real shares of Exelixis Inc. (EXEL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for EXEL and Place Your Order
Step 3: Search for EXEL and Place Your Order
Open the RealStocks trading page and search for EXEL. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Exelixis Inc. (EXEL) stock price today?
Exelixis Inc. (EXEL) is currently trading at $68.27, down 0.34% ($0.23) from the previous close of $68.50. Intraday prices update in real time during regular trading hours.
2.Is EXEL stock going up or down today?
As of 2026-11-19 00:47:00, EXEL is trading at $68.27, down 0.34% ($0.23) from its previous close of $68.50. The stock has traded between $68.09 and $69.44 during today’s regular session. Past price movements do not guarantee future results.
3.What is EXEL pre-market price?
As of 2026-11-19 00:47:00, EXEL is trading at $68.43 in pre-market trading, down 0.11% ($0.08) from the previous close of $68.50. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is EXEL after-hours price?
As of 2026-11-19 00:47:00, EXEL is trading at $67.96 in after-hours trading, down 0.45% ($0.31) from the regular-session close of $68.27. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is EXEL stock trading now?
EXEL trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does EXEL sit relative to its 52-week high and low?
Over the past 52 weeks, EXEL has traded between a low of $39.71 and a high of $73.69. At $68.27, the stock is positioned 84.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Exelixis Inc. in?
Exelixis Inc. (EXEL) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Exelixis Inc.'s market capitalization and where is it listed?
Exelixis Inc. is listed on the NASDAQ exchange with a market capitalization of $16.37B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is EXEL valued in terms of P/E ratio and EPS?
EXEL trades at a P/E ratio of 18.88, based on trailing-twelve-month EPS of $3.63. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Exelixis Inc. pay a dividend?
Exelixis Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to EXEL, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

EXEL Stock Calculator

Estimate the value between EXEL shares and USD.

EXEL Shares to USD

EXEL Shares
EXEL
EXEL
USD
USD
USD

1.00 EXEL shares = 68.265 USD

Calculations are estimates based on the latest available price and are for reference only.